ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: Diagnostic-therapeutic pathway in Italy

Maurizio Averna, Marcello Ciaccio, Gualtiero Ricciardi, Gerardo Medea, Damiano Parretti, Giovanni Battista Zito, Maria Stella Graziani, Roberto Ferrari, Marcello Ciaccio, Federico Nardi, Simona Giampaoli, Attilio Maseri, Furio Colivicchi, Pasquale Perrone Filardi, Michele Massimo Gulizia, Aldo Pietro Maggioni, Nicoletta Musacchio, Michele Massimo Gulizia, Nicoletta Musacchio, Nicoletta MusacchioClaudio Cricelli, Antonio Vittorio Panno, Marino Scherillo, Maurizio Giuseppe Abrignani, Giuseppe Musumeci, Ferruccio Ceriotti, Mauro Campanini, Andrea Di Lenarda, Enzo Bonora, Raffaele Griffo, Francesco Romeo, Maurizio Averna, Giorgio Cantelli Forti, Pompilio Massimo Faggiano, Francesco Perticone, Carmine Riccio, Alberico Catapano, Leonardo Bolognese, Alessandro Mugelli, Marcello Arca, Maria Pia Ruggieri, Francesco Rossi, Enrico Pusineri

Risultato della ricerca: Article

11 Citazioni (Scopus)

Abstract

Atherosclerotic cardiovascular disease still represents the leading cause of death in Western countries. A wealth of scientific evidence demonstrates that increased blood cholesterol levels have a major impact on the outbreak and progression of atherosclerotic plaques. Moreover, several cholesterol-lowering pharmacological agents, including statins and ezetimibe, have proved effective in improving clinical outcomes. This document focuses on the clinical management of hypercholesterolaemia and has been conceived by 16 Italian medical associations with the support of the Italian National Institute of Health. The authors discuss in detail the role of hypercholesterolaemia in the genesis of atherosclerotic cardiovascular disease. In addition, the implications for high cholesterol levels in the definition of the individual cardiovascular risk profile have been carefully analysed, while all available therapeutic options for blood cholesterol reduction and cardiovascular risk mitigation have been explored. Finally, this document outlines the diagnostic and therapeutic pathways for the clinical management of patients with hypercholesterolaemia.
Lingua originaleEnglish
pagine (da-a)3-54
Numero di pagine52
RivistaEUROPEAN HEART JOURNAL SUPPLEMENTS
Volume19
Stato di pubblicazionePublished - 2017

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Fingerprint Entra nei temi di ricerca di 'ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: Diagnostic-therapeutic pathway in Italy'. Insieme formano una fingerprint unica.

  • Cita questo

    Averna, M., Ciaccio, M., Ricciardi, G., Medea, G., Parretti, D., Zito, G. B., Graziani, M. S., Ferrari, R., Ciaccio, M., Nardi, F., Giampaoli, S., Maseri, A., Colivicchi, F., Perrone Filardi, P., Gulizia, M. M., Maggioni, A. P., Musacchio, N., Gulizia, M. M., Musacchio, N., ... Pusineri, E. (2017). ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: Diagnostic-therapeutic pathway in Italy. EUROPEAN HEART JOURNAL SUPPLEMENTS, 19, 3-54.